LLY

Eli Lilly And Co

BUY Analysis generated 2026-10-04 Market data as of 2026-11-12 Market data 3 days old USD 1425.55 Healthcare - Drug Manufacturers - GeneralREDUCE ZONE

ACTIONABLEMethodology gates passed

Position levels

Currenttoday

USD 1425.55

Buy <=wait / entry

USD 966.67

Trim >=take some off

USD 1180.00

Thesis breakSustained, regulatorily tolerated compounded tirzepatide supply that materially ...

Scenario-weighted conviction

	Probability	Score	Contribution
Bull case	44%	100 / 100	44.0
Base case	51%	62 / 100	31.6
Bear case	5%	10 / 100	0.5
Weighted conviction			76 / 100 - BUY

Top risks

FDA approval of additional indication for Jaypirca (pirtobrutinib)
$100 million partnership and multi-drug research collaboration with InnoCare Pharma
Collaboration and licensing deals signed with unit of China's Haisco

Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.